Latest News about CPRX
Recent news which mentions CPRX
Why a Clutch of Pharmaceutical and Biotech Stocks Escaped the Market's Swoon on Thursday
Today 16:50 EDT
From Motley Fool
Celsius, Lucid And Signet Are Among Top 10 Mid-Cap Gainers Last Week (Mar 17-Mar 21): Are The Others In Your Portfolio?
March 23, 2025
From Benzinga
Here's What's Driving Catalyst Pharmaceuticals Stock 8% Higher Today
February 27, 2025
Tickers
CPRX
From Motley Fool
Earnings Scheduled For February 26, 2025
February 26, 2025
From Benzinga
This Expand Energy Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
February 04, 2025
From Benzinga
Beyond The Numbers: 6 Analysts Discuss Catalyst Pharmaceuticals Stock
February 04, 2025
Tickers
CPRX
From Benzinga
From Benzinga
Top 3 Health Care Stocks That May Crash In August
August 14, 2024
From Benzinga
Tickers
CPRX
From InvestorPlace
From Benzinga
From Motley Fool
Tickers
CPRX
From InvestorPlace
Decoding 7 Analyst Evaluations For Catalyst Pharmaceuticals
March 27, 2024
Tickers
CPRX
From Benzinga
From InvestorPlace
7 Biotech Stocks Ready to Ride the Sector’s Resurgence
March 18, 2024
From InvestorPlace
3 Sexy Small-Cap Stocks to Add Sizzle to Your Portfolio
March 10, 2024
From InvestorPlace
From Motley Fool
Top 3 Health Care Stocks You May Want To Dump In Q1
February 29, 2024
From Benzinga
Jim Cramer Likes This Bank 'Very, Very Much,' Says Stock Is Up 7% Over Past 6 Months
January 22, 2024
From Benzinga
From InvestorPlace
3 Biotech Stocks You Can Buy and Hold for the Next Decade
January 15, 2024
From Motley Fool
Tickers
CPRX
From Motley Fool
3 Unstoppable S&P 600 Small-Cap Stocks to Buy in January
January 08, 2024
From InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Register for free